What must happen Before datalock & evaluation?

New Post Public Reply Private Reply Replies (1) Message Board
rockyracoon
635
Before datalock these things must happen:

Clinical Data Collection, Cleaning and Verification in Anticipation of Database Lock

Practices and Recommendations
Vera Pomerantseva & Olga Ilicheva
Pharmaceutical Medicine volume 25, pages 223–233 (2011)

Abstract
The gathering of data is central to the evaluation of new and approved drugs and every stage of trial design and data collection involves a set of cleaning and validation procedures to ensure the validity of the data. Preparation for data cleaning and validation must begin before the actual data are entered into the database and continue until the end of the data collection process. Data collection instruments have a big impact on the design of data management activities in terms of possible error types and their prevention methods, data load timelines and data verification options. Quality control must be applied at every stage of data handling and the data error rate should be estimated and recorded in the data management master file. The acceptable error rate for a database varies in the industry, but a popular choice is 0.5% overall, with 02–0.1% for critical variables and 0.22–1% for non-critical variables. Data management plans or other referenced documents should define data entry and processing plans. The minimum standard requirement is to document any findings and corrective actions, perform at least one quality assessment before database lock, use statistically appropriate sample study population sizes for decision making and determine separate acceptable error rates for primary and secondary safety and efficacy variables. Best practice recommendations for more complex procedures include: (i) performing quality control on whole-study populations (not just sample sizes), especially for variables that are related to primary and secondary endpoint evaluations; (ii) comparing trial data at multiple timepoints; (iii) monitoring data by site to detect which data differ significantly, so that appropriate corrective actions can be taken; and (iv) developing quantitative methods to measure data quality. The data manager has to ensure completion of all visits and assessments by all study subjects before initiating database lock. Once all of the data have been transferred and captured in the database, final cleaning, reconciliation and verification activities can be performed. All queries must be clarified. Having multiple incremental soft locks at certain timepoints of the study is a very effective tool for ensuring valid data. The lock of a database is a very important milestone in a study and once the final database lock has occurred, no further changes can be made without special permission. Before everyone moves on to new projects and forgets details, managers should allocate time to make sure that the study documentation is complete and that feedback from the study is recorded. Right after the lock is a good time to review the case report form fields that caused difficulties, or to add notes to the file to record any unusual circumstances that may have occurred. This is also a perfect time to review the metrics from the study such as the total number of pages, total number of discrepancies, percentages of discrepancies resolved inhouse, average time to resolve queries and time from the last query until study database lock. The locked database should remain in the system for at least 3 months before it is archived.

This is a preview of subscription content, access via your institution.
References
1.
Wayne Eckerson. Who ensures clean, consistent data. The Data Warehouse Institute, 2009 Sep [online]. Available from URL: http://www.sas.com/resources/asset/104222_1009.pdf [Accessed 2011 Apr 8]
Google Scholar

2.
Society for Clinical Data Management. Good clinical data management practices (GCDMP). 4th version. Milwaukee (WI): Society for Clinical Data Management, 2007
Google Scholar

3.
Institute of Medicine. Assuring data quality and validity in clinical trials for regulatory decision making: workshop report [online]. Available from URL: http://www.iom.edu/Reports/1999/Assuring-Data...eport.aspx [Accessed 2011 June 27]

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Ronald A Phillips
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lennar Lawsuit Puts Land-Light Claims Under a Microscope

Updated Category News Views 118

Three ugly selloffs, a murky land-bank story, and a fresh securities complaint have turned Lennar into the sort of holding that makes shareholders reread every footnote. The lawsuit is not a verdict, and the allegations remain unproven, but the timeline is nasty enough that investors in NYSE:LEN should not shrug it off as ordinary housing-cycle turbulence. The Dates...

Continue Reading
V2’s FOAS Bets on Candid Ad Sales Operator Dialogue

Updated Category News Views 180

Ad sales rarely gets fixed by another ballroom panel, and V2 seems to know it. Its new Future of Ad Sales, or FOAS, forum is built around a simpler premise: put senior operators in a small room, keep vendors and conference theatrics out of the way, and let people compare the ugly real-world details of running revenue machines. Announced November 19, 2026, FOAS is an...

Continue Reading
Vail Resorts Bets on Music to Deepen Epic Pass Demand

Updated Category News Views 119

A bass drop at 11,000 feet is not merely a party trick when you run 42 mountain resorts. Vail Resorts is putting live music, après programming and destination events squarely beside skiing and riding for winter 2026-27, and the business logic is pretty plain: give people another reason to buy early, stay longer and return with friends. For investors watching MTN, this is...

Continue Reading
BreakBio's New CSO Adds Vaccine Trial Credibility in Cancer

Updated Category News Views 144

Personalized cancer vaccines have no shortage of grand promises; seasoned clinical operators are the rarer commodity. That is why BreakBio's appointment of Dr. Greg Lizée as chief scientific officer deserves a closer look, even if nobody should confuse an executive hire with clinical validation. BreakBio is private, its lead program remains in development, and cancer...

Continue Reading
Huhtamaki Maps Its 2027 Reporting Dates for Investors

Updated Category News Views 17

A calendar release rarely makes the pulse race, but it tells shareholders when the curtain will actually go up. Huhtamäki Oyj has laid out its 2027 financial reporting timetable, and the useful part is its plainness: investors now know the handful of dates when management will have to put numbers, not broad ambitions, in front of the market. For a packaging company, that...

Continue Reading
Siteimprove Turns Accessibility Checks Into Agent Spend

Updated Category News Views 153

Accessibility work has usually been the thing teams promise to fix after the launch party is over. Siteimprove is trying to shove that discipline directly into the AI-agent workflow, announcing on November 19, 2026 that its Siteimprove.ai Accessibility Agent is available through Agentic Commerce on AWS Marketplace. The practical hook is simple enough: an AI agent can...

Continue Reading
Hard Rock Tampa Bets $30 Million on Smoke-Free Play

Updated Category News Views 71

Cigarette smoke is getting treated like a revenue problem in Tampa, and that is a far more interesting signal than another ribbon-cutting photo. Seminole Hard Rock Hotel & Casino Tampa opened The Breeze: A Smoke-Free Experience by Hard Rock on Nov. 19, 2026, following a $30 million transformation aimed at guests who want clean-air casino time from arrival through...

Continue Reading
Colossal's Halloween Campaign Wins Top Communicator Honor

Updated Category News Views 76

A horror-themed fan competition putting money toward hospitalized children is not the usual awards-season material, which is precisely why Colossal's latest recognition lands with some weight. The Phoenix-based professional fundraiser received an Award of Excellence, the top honor at the 32nd annual Communicator Awards, for its Face of Halloween campaign in the Innovation...

Continue Reading
Makera A1S Tests the Desktop CNC Metal-Cutting Promise

Updated Category News Views 84

Aluminum chips are where desktop-machine marketing stops bluffing, and Makera is leaning right into that test with the A1S. The company opened global pre-orders on November 18 for a machine aimed squarely at the awkward middle ground: users who have outgrown entry-level hobby gear but do not have room, budget, or patience for a full industrial setup. That is a real market...

Continue Reading
Genome-Written XDP Mice Could Sharpen Drug Research

Updated Category News Views 88

Seventy-eight thousand DNA letters changed the pace of a cruel little-known disease story. NYU Langone researchers inserted a human disease-linked stretch of genetic material into mice and produced an accelerated model of X-linked dystonia-parkinsonism, or XDP. That is a serious laboratory accomplishment, not a cure announcement, and it deserves to be read with both...

Continue Reading

Top 5 Most Recently Viewed Articles

Canada Nickel Secures EDC Interest for $500 Million Financing

Updated Category News Views 137

Canada Nickel's Significant Financing Achievement Canada Nickel Company Inc. is excited to share a major milestone in its efforts to secure financing for the Crawford Nickel Sulphide Project. The company has received a Letter of Interest (LOI) from Export Development Canada (EDC), indicating its intention to offer up to US$500 million in long-term debt financing for the...

Continue Reading
BlackRock Expands Offerings with New ETF Share Class Approval

Updated Category News Views 202

BlackRock Pursues SEC Approval for ETF Share Classes BlackRock Inc (NYSE: BLK) is making headlines as it has formally applied to the U.S. Securities and Exchange Commission (SEC) for a ruling that would allow the establishment of exchange-traded fund (ETF) share classes linked to its existing mutual funds. This significant move positions BlackRock as the largest firm...

Continue Reading
Profusa Unveils Innovative AI Portal for Continuous Biochemistry Monitoring

Updated Category News Views 133

Profusa Introduces AI-Powered Insight Portal for Biomarker Monitoring Profusa, a pioneering company in digital health technology, is transforming how healthcare providers monitor patient biochemistry through an innovative AI-driven insight portal. This advanced portal will enhance continuous biomarker tracking, utilizing cutting-edge technology to provide clinical...

Continue Reading
Investigation Launch for Pliant Therapeutics Investors: What to Know

Updated Category News Views 192

Investigation of Pliant Therapeutics, Inc. Pliant Therapeutics, Inc. (NASDAQ: PLRX) is currently under scrutiny as investors seek clarity on potential securities law violations. This investigation presents an opportunity for shareholders who believe they have been misled regarding their investments. Shareholders are encouraged to come forward to ensure their rights are...

Continue Reading
Fish Window Cleaning's New Headquarters: A Step Forward in Growth

Updated Category News Views 2161

Fish Window Cleaning Unveils New Corporate Headquarters Fish Window Cleaning Services is excited to announce the grand opening of its brand-new corporate headquarters, a facility that signifies an important milestone in its growth and operational capabilities. Located at 217 Chesterfield Towne Centre, this expansive 12,500-square-foot space is intended to serve as the...

Continue Reading